Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Humanwell Healthcare (Group) Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Humanwell Healthcare (Group) Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Humanwell Healthcare (Group) Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Humanwell Healthcare (Group) Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Humanwell Healthcare (Group) Co Ltd, Medical Devices Deals, 2012 to YTD 2018 10
Humanwell Healthcare (Group) Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Humanwell Healthcare (Group) Co Ltd, Pharmaceuticals & Healthcare, Deal Details 13
Venture Financing 13
Ambrx Raises USD45 Million in Venture Financing 13
Private Equity 15
AGIC Capital Acquires Ritedose From Olympus Partners 15
Licensing Agreements 17
Elite Pharma Enters into Licensing Agreement with Epic Pharma for Abuse-Deterrent ELI-200 17
Elite Pharma Enters Into Licensing Agreement With Epic Pharma For Twelve Generic Products 18
Equity Offering 19
Humanwell Healthcare Decreases Size of Private Placement of Shares for USD174 Million 19
Wuhan Humanwell Healthcare Plans Private Placement of Shares for up to USD412.5 Million 20
Wuhan Humanwell Hi-tech Industry Plans For Private Placement Of Shares For Up To US$163 Million 21
Debt Offering 22
Humanwell Healthcare to Raise USD302 Million in Private Placement of Notes 22
Humanwell Healthcare Raises USD150.8 Million in First Tranche of 4.99% Public Offering of Notes Due 2018 23
Humanwell Healthcare to Raise USD296.81 Million in Commercial Paper Offering 24
Humanwell Healthcare Raises USD224 Million in Public Offering of Notes 25
Humanwell Healthcare Plans to Raise USD309 Million in Public Offering of Notes 26
Humanwell Healthcare to Raise up to USD155 Million in Public Offering of Bonds 27
Wuhan Humanwell Announces Public Offering Of Notes Due 2015 For US$95 MIllion 28
Acquisition 29
CSL to Acquire Remaining 20% Stake in Wuhan Zhong Yuan Rui De Biological Products from Humanwell Healthcare Group for USD102 Million 29
Humanwell Healthcare Sells Bio-Pharma Unit for USD53 Million 30
CSL Acquires 80% Equity Stake in Wuhan Zhong Yuan Rui De Biological Products from Humanwell Healthcare Group for USD352 Million 31
Humanwell Healthcare and PuraCap Pharma Acquire 100% Stake in Epic Pharma 32
Humanwell Healthcare Acquires Epic RE Holdco for USD21 Million 34
Humanwell Healthcare Plans to Acquire 70% Stake in Chengdu Kanghong Pharma for USD53 Million 35
Humanwell Healthcare Plans to Sell Shenzhen Biotech Firm for USD36 Million 36
Humanwell Healthcare to Acquire Yichang Sanxia Pharmaceutical for USD71.06 Million 37
Humanwell Healthcare Plans to Acquire 70% Stake in Pharmaceutical Firm for USD40 Million 38
Humanwell Healthcare (Group) Co Ltd – Key Competitors 39
Humanwell Healthcare (Group) Co Ltd – Key Employees 40
Humanwell Healthcare (Group) Co Ltd – Locations And Subsidiaries 41
Head Office 41
Other Locations & Subsidiaries 41
Appendix 42
Methodology 42
About GlobalData 42
Contact Us 42
Disclaimer 42
Humanwell Healthcare (Group) Co Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Humanwell Healthcare (Group) Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Humanwell Healthcare (Group) Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Humanwell Healthcare (Group) Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Humanwell Healthcare (Group) Co Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Humanwell Healthcare (Group) Co Ltd, Medical Devices Deals, 2012 to YTD 2018 10
Humanwell Healthcare (Group) Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Ambrx Raises USD45 Million in Venture Financing 13
AGIC Capital Acquires Ritedose From Olympus Partners 15
Elite Pharma Enters into Licensing Agreement with Epic Pharma for Abuse-Deterrent ELI-200 17
Elite Pharma Enters Into Licensing Agreement With Epic Pharma For Twelve Generic Products 18
Humanwell Healthcare Decreases Size of Private Placement of Shares for USD174 Million 19
Wuhan Humanwell Healthcare Plans Private Placement of Shares for up to USD412.5 Million 20
Wuhan Humanwell Hi-tech Industry Plans For Private Placement Of Shares For Up To US$163 Million 21
Humanwell Healthcare to Raise USD302 Million in Private Placement of Notes 22
Humanwell Healthcare Raises USD150.8 Million in First Tranche of 4.99% Public Offering of Notes Due 2018 23
Humanwell Healthcare to Raise USD296.81 Million in Commercial Paper Offering 24
Humanwell Healthcare Raises USD224 Million in Public Offering of Notes 25
Humanwell Healthcare Plans to Raise USD309 Million in Public Offering of Notes 26
Humanwell Healthcare to Raise up to USD155 Million in Public Offering of Bonds 27
Wuhan Humanwell Announces Public Offering Of Notes Due 2015 For US$95 MIllion 28
CSL to Acquire Remaining 20% Stake in Wuhan Zhong Yuan Rui De Biological Products from Humanwell Healthcare Group for USD102 Million 29
Humanwell Healthcare Sells Bio-Pharma Unit for USD53 Million 30
CSL Acquires 80% Equity Stake in Wuhan Zhong Yuan Rui De Biological Products from Humanwell Healthcare Group for USD352 Million 31
Humanwell Healthcare and PuraCap Pharma Acquire 100% Stake in Epic Pharma 32
Humanwell Healthcare Acquires Epic RE Holdco for USD21 Million 34
Humanwell Healthcare Plans to Acquire 70% Stake in Chengdu Kanghong Pharma for USD53 Million 35
Humanwell Healthcare Plans to Sell Shenzhen Biotech Firm for USD36 Million 36
Humanwell Healthcare to Acquire Yichang Sanxia Pharmaceutical for USD71.06 Million 37
Humanwell Healthcare Plans to Acquire 70% Stake in Pharmaceutical Firm for USD40 Million 38
Humanwell Healthcare (Group) Co Ltd, Key Competitors 39
Humanwell Healthcare (Group) Co Ltd, Key Employees 40
Humanwell Healthcare (Group) Co Ltd, Subsidiaries 41
List of Figures
Humanwell Healthcare (Group) Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Humanwell Healthcare (Group) Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Humanwell Healthcare (Group) Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Humanwell Healthcare (Group) Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Humanwell Healthcare (Group) Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Humanwell Healthcare (Group) Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Humanwell Healthcare (Group) Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Humanwell Healthcare (Group) Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Humanwell Healthcare (Group) Co Ltd, Medical Devices Deals, 2012 to YTD 2018 10
【免責事項】
http://www.globalresearch.jp/disclaimer